Alinity m reagents exercise option #2
Ended Awarded Last action
- Contract number
- 36C24224N0409
- Awardee
-
Abbott Molecular Inc. UEI NK5QDVJBHMN7 Part of Abbott Laboratories
- Awarding agency
-
Veterans Integrated Service Network 2
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $580,248
Award facts
- Contract value 100% obligated
- $580,247.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Rosemont, IL 60018, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$898,621 | |
| Original award | $1,478,869 |
About this award
Abbott Molecular Inc., a subsidiary of Abbott Laboratories, was awarded a contract modification on May 15, 2024, for Alinity M Reagents under Exercise Option #2, with a ceiling value of $580,247.67. This award represents a Blanket Purchase Agreement (BPA) call with firm fixed-price pricing issued by Veterans Integrated Service Network 2 (VISN 2), a civilian component of the Department of Veterans Affairs. The contract carries no small business set-aside designation and specifies performance completion by May 14, 2025, with work to be performed in Des Plaines, Illinois. This procurement falls within Abbott Molecular's established role as a critical supplier of molecular diagnostic reagents and testing solutions to the VA healthcare system.
The award is part of a larger $12.5 million BPA that Abbott Molecular holds with the VA for Alinity diagnostics reagents, reflecting the company's established position as a preferred provider of in-vitro diagnostic supplies under GSA Schedule contracts, particularly the In-Vitro Diagnostics, Reagents, Test (FSS-65-VII) schedule. The Alinity platform represents Abbott Molecular's advanced diagnostic analyzer system used across multiple VA medical centers for molecular testing capabilities. This modification exercise demonstrates the ongoing demand for reagent supplies to support the VA's diagnostic testing operations across its integrated service networks.
Quick answers
Who was awarded contract 36C24224N0409?
36C24224N0409 was awarded to Abbott Molecular Inc. by Veterans Integrated Service Network 2 (Veterans Health Administration) on May 15, 2024.
How much is contract 36C24224N0409 worth?
The government has obligated $580,248 on 36C24224N0409.
Is contract 36C24224N0409 an order under another contract?
Yes. 36C24224N0409 is a BPA call under 36C24222A0027, a blanket purchase agreement.
Was contract 36C24224N0409 competed?
The extent of competition for 36C24224N0409 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award